Precise Biometrics

First quarter

• Net sales totaled SEK 20.0 (21.7) million
  • A change in revenue allocation in a renegotiated customer agreement results in higher revenue on an annual basis, but has an impact of SEK -1.0 million on net sales in the first quarter.
• EBITDA totaled SEK -1.7 (3.1) million
  • Adjusted for negative currency effects from operating items of SEK 1.6 million and a change in revenue allocation in a customer agreement of SEK 1.0 million, EBITDA amounts to SEK 0.9 million
• Cash flow from operating activities totaled SEK 2.1 (-2.8) million
• The operating profit/loss (EBIT) totaled SEK -7.1 (-2.8) million
• Earnings for the period totaled SEK -7.2 (-3.0) million
• Earnings per share before and after dilution totaled SEK -0.1 (-0.0)
• ARR (Annual Recurring Revenue) at the end of the period was SEK 18.4 (18.3) million

Significant events during the quarter

• The anti-spoof solution BioLive approved for national ID program
• The Nomination Committee proposes Victor Kuzmin for the Board of Directors
• Entering the Norwegian visitor management system market
• Expanded biometric physical access offering for high-security sector
• Showcasing Biometric Security Solutions at ISC West in Las Vegas
• Västra Hamnen Corporate Finance initiates coverage of Precise
• Xiaomi launches new smart safe with technology from Precise

Significant events after the end of the interim period

• Rebranding initiative to clarify and strengthen Precise’s offering

Presentation and Q&A
Precise has published a video interview with CEO Joakim Nydemark in connection with this report.
The video is available on the Investor Relations page: https://precisebiometrics.com/investors/.

The company also invites you to a live Q&A session May 14, 2025, at 13:00 (CET). More information and registration link to the Q&A session may be found on the Investor Relations page: https://precisebiometrics.com/investors/.
The Q&A is in Swedish but questions can be asked in English.

CEO Joakim Nydemark comments

“We continue to see strong demand for our products, and I believe our offering is stronger and more relevant than ever. While our Q1 results did not reach the levels of recent quarters, due to quarterly fluctuations and global market turbulence, I remain positive about the full-year 2025. I view the Q1 outcome as a temporary dip, and we remain fully focused on executing our commercialization strategy and the growth journey that has only just begun.”